Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
AUTOR(ES)
Averbeck, Marcio Augusto
FONTE
International braz j urol
DATA DE PUBLICAÇÃO
2022
RESUMO
Documentos Relacionados
- Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity
- Editorial Comment: Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction
- Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
- Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity
- Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity